These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6650352)

  • 1. Clinical characteristics and results of electrophysiologic testing in young adults with ventricular tachycardia or ventricular fibrillation.
    Morady F; Scheinman MM; Hess DS; Chen R; Stanger P
    Am Heart J; 1983 Dec; 106(6):1306-14. PubMed ID: 6650352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
    Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH
    Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of programmed stimulation methods in the evaluation of ventricular arrhythmias in patients 20 years old and younger.
    Silka MJ; Kron J; Cutler JE; McAnulty JH
    Am J Cardiol; 1990 Oct; 66(10):826-30. PubMed ID: 2220580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ventricular fibrillation versus monomorphic ventricular tachycardia during programmed stimulation. Role of premature beat conduction delay.
    Avitall B; McKinnie J; Jazayeri M; Akhtar M; Anderson AJ; Tchou P
    Circulation; 1992 Apr; 85(4):1271-8. PubMed ID: 1372847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
    Kuchar DL; Garan H; Venditti FJ; Finkelstein D; Rottman JN; McComb J; McGovern BA; Ruskin JN
    Am J Cardiol; 1989 Jul; 64(1):33-6. PubMed ID: 2741811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
    Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
    Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitation of ventricular tachyarrhythmia induction by isoproterenol.
    Freedman RA; Swerdlow CD; Echt DS; Winkle RA; Soderholm-Difatte V; Mason JW
    Am J Cardiol; 1984 Oct; 54(7):765-70. PubMed ID: 6486026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
    Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of ventricular tachycardia suppression by antiarrhythmic drug therapy during serial electrophysiologic testing in coronary artery disease.
    Garan H; Stavens CS; McGovern B; Kelly E; Ruskin JN
    Am J Cardiol; 1986 Nov; 58(10):977-80. PubMed ID: 3776854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest.
    Morady F; Scheinman MM; Hess DS; Sung RJ; Shen E; Shapiro W
    Am J Cardiol; 1983 Jan; 51(1):85-9. PubMed ID: 6849269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing.
    Morady F; Shen E; Schwartz A; Hess D; Bhandari A; Sung RJ; Scheinman MM
    J Am Coll Cardiol; 1983 Dec; 2(6):1053-9. PubMed ID: 6630777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the signal-averaged electrocardiogram in patients presenting with sustained ventricular tachycardia or fibrillation while on an antiarrhythmic drug.
    Nalos PC; Gang ES; Mandel WJ; Myers MR; Oseran DS; Lass Y; Peter T
    Am Heart J; 1988 Jan; 115(1 Pt 1):108-14. PubMed ID: 3336965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of electrophysiologic testing in patients resuscitated from documented ventricular fibrillation.
    Li HG; Thakur RK; Yee R; Klein GJ
    J Cardiovasc Electrophysiol; 1994 Oct; 5(10):805-9. PubMed ID: 7874325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation.
    Anderson JL; Reid PR; Platia EV; Akhtar M; Ruskin JN; Schaal SF; Jueng P; Long RA; Wenger TL
    Am Heart J; 1985 Oct; 110(4):774-84. PubMed ID: 3901715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.
    Lerman BB; Waxman HL; Buxton AE; Josephson ME
    Am J Cardiol; 1983 Mar; 51(5):759-64. PubMed ID: 6829435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic mechanism of exercise-induced sustained ventricular tachycardia.
    Sung RJ; Shen EN; Morady F; Scheinman MM; Hess D; Botvinick EH
    Am J Cardiol; 1983 Feb; 51(3):525-30. PubMed ID: 6823868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.